Cutting Angioplasty Balloons Market Revenue to Exceed USD 360.0 Million by 2031, Driven by Increasing Cardiovascular Disease Prevalence and Advancements in Balloon Technology - Exclusive Report by Transparency Market Research, Inc.

Cutting angioplasty balloons are innovative medical devices used in the treatment of coronary artery disease-a condition characterized by plaque buildup that narrows the arteries and restricts blood flow to the heart. Unlike traditional angioplasty balloons, these devices are equipped with microsurgical blades that make precise incisions into the plaque, facilitating its compression and the reshaping of the arterial wall.

Valued at US$ 205.9 million in 2022, the global market is poised to grow significantly, reaching over US$ 360.0 million by 2031, with a projected CAGR of 6.4% over the forecast period. The increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures are key factors propelling this growth.

Discover essential conclusions and data from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85449

Analysts' Viewpoint

Industry experts believe that the cutting angioplasty balloons market is set to experience robust growth in the coming years. The escalating incidence of coronary artery disease and the expanding geriatric population are major contributors to this trend. In addition, the development of advanced devices-featuring enhanced durability, flexibility, and drug-coated technology-is enabling manufacturers to differentiate their offerings and capture a larger share of the market. Despite challenges such as higher production costs compared to conventional balloons, the emphasis on improved patient outcomes and reduced procedural risks is expected to drive market expansion.

Market Drivers

Rise in Prevalence of Cardiovascular Diseases

Global Health Burden: Cardiovascular diseases account for a significant proportion of global mortality, with unhealthy lifestyles and an aging population fueling the rise in cases.

Need for Advanced Treatments: The increasing rate of coronary artery disease necessitates innovative solutions, making cutting angioplasty balloons a critical tool in achieving better treatment outcomes.

Technological Advancements in Balloon Technology

Drug-Coated Cutting Balloons: These devices are designed to deliver therapeutic agents directly to the site of plaque accumulation, significantly reducing the risk of restenosis and minimizing the need for repeat interventions.

Enhanced Design and Imaging Integration: Manufacturers are incorporating advanced materials and imaging technologies such as Intravascular Ultrasound (IVUS) and optical coherence tomography (OCT) to improve the precision and safety of the procedure.

Increased Adoption of Minimally Invasive Procedures

Patient Benefits: Minimally invasive techniques using cutting angioplasty balloons result in less trauma, faster recovery, and lower complication rates, which are increasingly preferred by healthcare providers and patients alike.

Growing Infrastructure: The rise in specialized hospitals and cardiac centers, particularly in developed regions, supports the expanding use of these advanced devices.

Access our report for a comprehensive look at key insights -

https://www.transparencymarketresearch.com/cutting-angioplasty-balloons-market.html

Product Segmentation

By Product Type

Drug-Coated Cutting Balloons: Designed for targeted drug delivery to prevent restenosis, these balloons are witnessing accelerated adoption.

Conventional Cutting Balloons: Utilized in cases requiring precise plaque incisions for arterial expansion.

Scoring Balloons: Engineered to optimize plaque modification, providing an alternative option for complex lesions.

By Application

Coronary Artery Disease: The primary application area, driven by the high prevalence of the condition worldwide.

Peripheral Artery Disease: An emerging segment as these devices are increasingly used for non-coronary arterial conditions.

By End-user

Hospitals: With extensive patient inflow and advanced technological infrastructure, hospitals are the leading adopters.

Cardiac Centers and Others: Specialized facilities that contribute significantly to market growth.

Regional Outlook

North America
North America is expected to dominate the cutting angioplasty balloons market, supported by a robust healthcare infrastructure, high incidence of cardiovascular diseases, and favorable reimbursement policies.

Europe
Europe will witness steady growth due to ongoing innovations, stringent quality standards, and the presence of major market players, ensuring a favorable environment for advanced medical devices.

Asia Pacific
Asia Pacific is projected to grow at a significant pace, driven by rising healthcare investments, expanding infrastructure, and an increasing geriatric population, particularly in countries like China, India, and Japan.

Competitive Landscape

The cutting angioplasty balloons market is characterized by intense competition among key players such as Abbott, Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Cordis, Medtronic, MicroPort Scientific Corporation, Opto Circuits (India) Ltd., Spectranetics (Philips Healthcare), Terumo Corporation, TriReme Medical, LLC (QT Vascular Ltd.), and Vascular Concepts Limited. These companies are focused on strategic initiatives including mergers, acquisitions, product innovations, and R&D investments to enhance their product portfolios and maintain a competitive edge. Recent developments, such as the marketing approval of new drug-coated cutting balloon systems, underscore the market's dynamic and innovative nature.

Future Outlook

The global cutting angioplasty balloons market is positioned for significant growth, driven by:
Increased Cardiovascular Disease Incidence: A continuous rise in coronary artery and peripheral artery diseases will boost market demand.

Technological Innovation: Advancements in drug-coating and imaging integration are set to improve Expansion in Emerging Markets: Growing healthcare infrastructure in emerging economies will create new growth avenues.

Strategic Collaborations: Partnerships and investments in R&D will further propel market expansion and product development.

Buy this Premium Research Report to access comprehensive analysis -

https://www.transparencymarketresearch.com/checkout.php?rep_id=85449<ype=S

FAQs

Q1: What are cutting angioplasty balloons used for?
A: They are specialized medical devices used to treat coronary artery disease by making precise incisions in plaque, facilitating effective arterial expansion.

Q2: What factors are driving the market growth for cutting angioplasty balloons?
A: Key drivers include the increasing prevalence of cardiovascular diseases, technological advancements in balloon design, and the growing adoption of minimally invasive procedures.

Q3: What is the market forecast value by 2031?
A: The market is projected to exceed US$ 360.0 million by 2031, growing at a CAGR of 6.4% from 2023 to 2031.

Q4: Which product segment is expected to dominate the market?
A: The drug-coated cutting balloons segment is anticipated to dominate, owing to their ability to reduce restenosis and improve long-term patient outcomes.

Q5: Who are the major end-users of cutting angioplasty balloons?
A: Major end-users include hospitals, cardiac centers, and other specialized healthcare facilities.

This robust growth is driven by the rising prevalence of cardiovascular diseases, technological innovations in balloon design, and the expanding adoption of minimally invasive procedures. As key players continue to invest in R&D and strategic collaborations, the market is poised to deliver enhanced patient outcomes and reshape cardiovascular treatment paradigms globally.

Explore Latest Research Reports by Transparency Market Research:

Biomarkers Market - https://www.transparencymarketresearch.com/biomarkers-market.html

Endoscopic Stricture Management Device Market - https://www.transparencymarketresearch.com/endoscopic-stricture-management-device-market.html

Flowable Hemostats Market - https://www.transparencymarketresearch.com/flowable-hemostats-market.html

Hormonal Contraceptive Market - https://www.transparencymarketresearch.com/hormonal-contraceptives-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.